Anonymous ID: 327962 May 1, 2021, 9:50 p.m. No.13561757   🗄️.is 🔗kun

>>13503244 PB

>>13561409 PB

>>13561430 PB

 

The CDC's ACIP committee has its FDA counterpart, the Vaccines and Related Biological Products Advisory Committee (VBPAC). These are the dolts who recommended the Pfizer BioNTech and Moderna vaxes get emergency authorization for use in this "plandemic".

 

"The Committee reviews and evaluates data concerning the safety, effectiveness, and appropriate use of vaccines and related biological products which are intended for use in the prevention, treatment, or diagnosis of human diseases, and, as required, any other products for which the Food and Drug Administration has regulatory responsibility. The Committee also considers the quality and relevance of FDA's research program which provides scientific support for the regulation of these products and makes appropriate recommendations to the Commissioner of Food and Drugs."

 

At the top of the page is a low-key note about applying for membership on the committee: they want "qualified experts with minimal conflicts of interest". Note that Amanda Cohn serves on the VRBPAC and is also the Executive Secretary of the CDC's ACIP with the CDC job title "Senior Advisor for Vaccines". Also check out how many state associations of epidemiologists there are. How can so many "experts" be so ignorant on PCR test cycles, or ignorant on hospital payment incentives to tag patients as covid-related? The complicity of silence on this fake epidemic is enormous.

 

Source: https://web.archive.org/web/20210428213933/https://www.fda.gov/advisory-committees/blood-vaccines-and-other-biologics/vaccines-and-related-biological-products-advisory-committee

 

FDA Committee Recommends Emergency Use Authorization for Moderna’s COVID-19 Vaccine

[December 17, 2020]

Moderna’s vaccine candidate for the coronavirus disease 2019 (COVID-19) has been recommended for Emergency Use Authorization (EUA) by the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC), according to the company.1 This new COVID-19 vaccine (mRNA-1273) candidate was deemed highly effective in a filing released by the VRBPAC on Tuesday."

  • https://www.pharmacytimes.com/view/fda-committee-recommends-emergency-use-authorization-for-modernas-covid-19-vaccine

 

FDA Grants Historic Emergency Use Authorization to COVID-19 Vaccine From Pfizer and BioNTech

[December 12, 2020]

An advisory committee for the US Centers for Disease Control and Prevention is expected to greenlight the vaccine on Saturday, The Washington Post reported. Initial doses of the mRNA vaccine have been earmarked for frontline health care workers and patients in high-risk categories.

On Thursday, the FDA’s Vaccines and Related Biological Products Advisory Committee voted 17 to 4 in support of granting an EUA for BNT162b2.

  • https://www.pharmacytimes.com/view/fda-grants-historic-emergency-use-authorization-to-covid-19-vaccine-from-pfizer-and-biontech